BA
SVNT

BlackRock Advisors’s SAVIENT PHARMACEUTICALS INC SVNT Stock Holding History

BlackRock Advisors’s Portfolio SVNT Stock Details SVNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-12,887
Closed -$8K – 3714
2013
Q3 		$8K Hold
12,887
– – ﹤0.01% 3508
2013
Q2 		$7K Buy
+12,887
New +$8.98K ﹤0.01% 3492

Other funds holding SVNT

Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
FHC
First Heartland Consultants Lake St. Louis, Missouri $1.55B AUM 20.5% 1-Year Est. Return
PSC
Prentiss Smith & Co Brattleboro, Vermont $172M AUM 21.18% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

BlackRock Advisors's SVNT Position: Q4 2013 in Review

BlackRock Advisors sold out of SAVIENT PHARMACEUTICALS INC (SVNT) in Q4 2013, closing a stake of 12,887 shares — an estimated $8K sold.

BlackRock Advisors first reported a position in SVNT in Q2 2013 and held it in 2 quarters. The position peaked at $8K in Q3 2013. 7 funds tracked by Wall St. Rank hold SVNT as of Q4 2013.

  • BlackRock Advisors reported no remaining SAVIENT PHARMACEUTICALS INC position as of Q4 2013 after selling out during the quarter.
  • BlackRock Advisors sold 12,887 SAVIENT PHARMACEUTICALS INC shares in Q4 2013, an estimated $8K.
  • BlackRock Advisors first reported a position in SAVIENT PHARMACEUTICALS INC in Q2 2013 and held it in 2 quarters.
  • BlackRock Advisors's SAVIENT PHARMACEUTICALS INC position peaked at $8K in Q3 2013.
  • 7 funds tracked by Wall St. Rank held SAVIENT PHARMACEUTICALS INC as of Q4 2013.

Based on BlackRock Advisors's 13F filing for Q4 2013, filed 12 Feb 2014.